Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 2
1992 2
1994 1
1995 3
1997 1
1998 2
1999 3
2000 2
2001 3
2002 2
2003 7
2004 5
2005 1
2006 5
2007 3
2008 3
2009 4
2010 6
2011 2
2012 4
2013 4
2014 7
2015 6
2016 5
2017 4
2018 3
2019 6
2020 6
2021 13
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Olmsted syndrome 2"
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. ...More than 96% …
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protei …
Olmsted Syndrome.
Huang YY, Li JH. Huang YY, et al. JAMA Dermatol. 2024 Feb 1;160(2):218-219. doi: 10.1001/jamadermatol.2023.4152. JAMA Dermatol. 2024. PMID: 38055272
2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013.
De Souza MJ, Nattiv A, Joy E, Misra M, Williams NI, Mallinson RJ, Gibbs JC, Olmsted M, Goolsby M, Matheson G; Expert Panel. De Souza MJ, et al. Br J Sports Med. 2014 Feb;48(4):289. doi: 10.1136/bjsports-2013-093218. Br J Sports Med. 2014. PMID: 24463911
The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves three components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction and (3) low bone mineral density. Female athletes of …
The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves three components: (1) low …
Olmsted syndrome.
Perry HO, Su WP. Perry HO, et al. Semin Dermatol. 1995 Jun;14(2):145-51. doi: 10.1016/s1085-5629(05)80011-2. Semin Dermatol. 1995. PMID: 7640195
Nine cases of Olmsted syndrome have been reported in the world literature. In this syndrome, keratoderma usually starts during infancy on the palms and soles when the baby starts to use the feet for walking and the hands for grasping. ...In the differential d …
Nine cases of Olmsted syndrome have been reported in the world literature. In this syndrome, keratoderma usually starts …
Sleep Disturbances Associated with Neurological Autoimmunity.
Devine MF, St Louis EK. Devine MF, et al. Neurotherapeutics. 2021 Jan;18(1):181-201. doi: 10.1007/s13311-021-01020-x. Epub 2021 Mar 30. Neurotherapeutics. 2021. PMID: 33786802 Free PMC article. Review.
Potential immune-mediated etiopathogenesis has been proposed for various sleep disorders including narcolepsy, Kleine-Levin syndrome, and Morvan syndrome. Sleep manifestations are also common in various autoimmune neurological syndromes, but may be underestim …
Potential immune-mediated etiopathogenesis has been proposed for various sleep disorders including narcolepsy, Kleine-Levin syndrome, …
Olmsted syndrome: clinical, molecular and therapeutic aspects.
Duchatelet S, Hovnanian A. Duchatelet S, et al. Orphanet J Rare Dis. 2015 Mar 17;10:33. doi: 10.1186/s13023-015-0246-5. Orphanet J Rare Dis. 2015. PMID: 25886873 Free PMC article. Review.
Olmsted syndrome (OS) is a rare genodermatosis classically characterized by the combination of bilateral mutilating transgredient palmoplantar keratoderma (PPK) and periorificial keratotic plaques, but which shows considerable clinical heterogeneity. ...OS has to be …
Olmsted syndrome (OS) is a rare genodermatosis classically characterized by the combination of bilateral mutilating transgredi …
Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability.
Johnson SA, Shouman K, Shelly S, Sandroni P, Berini SE, Dyck PJB, Hoffman EM, Mandrekar J, Niu Z, Lamb CJ, Low PA, Singer W, Mauermann ML, Mills J, Dubey D, Staff NP, Klein CJ. Johnson SA, et al. Neurology. 2021 Nov 30;97(22):e2236-e2247. doi: 10.1212/WNL.0000000000012894. Epub 2021 Oct 27. Neurology. 2021. PMID: 34706972 Free PMC article.
Large fiber neuropathy developed in 36%, on average 5.3 years (range 0.2-14.3 years) from SFN onset. Median onset Composite Autonomic Severity Score (CASS) was 3 (change per year 0.08, range 0-2.0). Median Neuropathy Impairment Scale (NIS) score was 2 at onse …
Large fiber neuropathy developed in 36%, on average 5.3 years (range 0.2-14.3 years) from SFN onset. Median onset Composite Autonomic …
Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes.
Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Shah S, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Dec 22;9(2):e1124. doi: 10.1212/NXI.0000000000001124. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34937736 Free PMC article.
OBJECTIVES: Population-based epidemiologic data for paraneoplastic neurologic syndromes (PNSs) in the United States are lacking. Our objective was to evaluate the incidence, prevalence, and associated morbidity of PNS. ...RESULTS: There were 28 patients with PNS identified …
OBJECTIVES: Population-based epidemiologic data for paraneoplastic neurologic syndromes (PNSs) in the United States are lacking. Our …
Incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis.
Cui RZ, Hodge DO, Mohney BG. Cui RZ, et al. J AAPOS. 2023 Oct;27(5):273.e1-273.e4. doi: 10.1016/j.jaapos.2023.07.006. Epub 2023 Sep 15. J AAPOS. 2023. PMID: 37716433
PURPOSE: To investigate the population-based incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis. METHODS: Patients newly diagnosed with Marfan syndrome in Olmsted County, Minnesota, from January 1, 1976, through December 31, 200 …
PURPOSE: To investigate the population-based incidence and de novo mutation rate of Marfan syndrome and risk of ectopia lentis. METHO …
Treatment Strategies for Generator Pocket Pain.
Bao J, Khazen O, Olmsted ZT, Gechtman G, Shao MM, DiMarzio M, Topp G, Sukul VV, Staudt MD, Pilitsis JG. Bao J, et al. Pain Med. 2021 Jun 4;22(6):1305-1311. doi: 10.1093/pm/pnab007. Pain Med. 2021. PMID: 33502508 Free PMC article.
Females were overrepresented in pocket pain cohort (76.7%) when compared with the total SCS cohort (59.0%) (X2 = 5.93, P = 0.015). Diagnosis included failed back surgery syndrome (51.2%), complex regional pain syndrome (23.3%), and chronic neuropathic pain (2 …
Females were overrepresented in pocket pain cohort (76.7%) when compared with the total SCS cohort (59.0%) (X2 = 5.93, P = 0.015). Diagnosis …
112 results